+ All Categories
Home > Documents > ANNUAL REPORT 2014 · 2020. 6. 4. · Dividends paid (559) (582) Net cash, (used in)/generated...

ANNUAL REPORT 2014 · 2020. 6. 4. · Dividends paid (559) (582) Net cash, (used in)/generated...

Date post: 01-Feb-2021
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
64
ANNUAL REPORT 2014
Transcript
  • ANNUAL REPORT

    2014

  • АLCOMET AD

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 25

    INCOME STATEMENT

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    Notes

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Revenue 4 293,535 279,671

    Cost of sales 5 (269,026) (256,291)

    Gross margin 24,509 23,380

    Other income 6 7,579 6,863

    Administrative expenses 7 (9,664) (9,423)

    Distribution expenses 8 (11,592) (10,586)

    Other expenses 9 (4,204) (4,430)

    Exchange rate gain/(loss), net 11 70 (182)

    Interest expenses, net 12 (3,666) (2,741)

    Other financial expenses net 13 (347) (389)

    Profit before taxation 2,685 2,492

    Income tax expense 14 (278) (254)

    Profit for the period 2,407 2,238

    Earning per share (BGN) 15 0.13 0.12

    Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015

    Huseyin Yorucu (signed)

    Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)

    Executive Directors Financial Director Chief Accountant

    Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)

    Managing Director Registered Auditor

    AndA Consulting Ltd

    March 4, 2015, Sofia

    The accompanying notes are an integral part of these financial statements.

  • АLCOMET AD

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 26

    STATEMENT OF COMPREHENSIVE INCOME

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    Notes

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Profit for the period 2,407 2,238

    Other comprehensive income

    Items,that will not be reclassified subsequently

    to profit or loss:

    Actuarial loss, incurred during the period 25 (53) (52)

    Tax effect on actuarial loss, incurred during the

    period

    5

    5

    (48) (47)

    Items,that may be reclassified subsequently

    to profit or loss:

    Adjustment of the hedging reserve for the

    loss/(gain) from forward contracts, transferred to

    the initial carrying amount of the hedged items 24

    1,157

    (183)

    Tax effect on the adjustment of the hedging reserve

    for the result from forward contracts, transferred

    to the initial carrying amount of the hedged items

    (116)

    18

    Unrealized profit/(loss) on forward contracts,

    recognized in the hedging reserve 24

    832

    (1,157)

    Tax effect on the unrealized profit/(loss) on

    forward contracts, recognized in the hedging

    reserve 24

    (83)

    116

    1,790

    (1,206)

    Total other comprehensive income for the period,

    net of tax

    1,742

    (1,253)

    TOTAL COMPREHENSIVE INCOME

    FOR THE PERIOD

    4,149

    985

    Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015

    Huseyin Yorucu (signed)

    Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)

    Executive Directors Financial Director Chief Accountant

    Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)

    Managing Director Registered Auditor

    AndA Consulting Ltd

    March 4, 2015, Sofia

    The accompanying notes are an integral part of these financial statements.

  • АLCOMET AD

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 27

    STATEMENT OF FINANCIAL POSITION

    as of December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    Notes

    December 31,

    2014

    December 31,

    2013

    ASSETS

    Non-current assets

    Property, plant and equipment 16 113,662 119,797

    Intangible assets 17 340 540

    Investment property 18 4,935 4,935

    Financial assets 19 5,650 5,500

    Deferred tax assets 14 201 419

    124,788 131,191

    Current assets

    Inventories 20 60,400 46,694

    Trade and other receivables, net 21 53,127 48,133

    Derivative financial instruments 24 879 -

    Cash and cash equivalents 22 4,709 733

    119,115 95,560

    TOTAL ASSETS 243,903 226,751

    EQUITY AND LIABILITIES

    Capital and reserves

    Share capital 23 17,953 17,953

    Legal reserve 23 1,795 1,795

    Revaluation reserve 23 55,830 56,145

    Hedging reserve 23 749 (1,041)

    Retirement benefits obligation reserve 23 (922) (874)

    Accumulated profit 23,693 21,531

    99,098 95,509

    Non-current liabilities

    Retirement benefits obligation 25 884 1,048

    Long-term borrowings 26 20,412 26,184

    Derivative financial instruments 24 - 27

    Deferred income 27 1,882 -

    Deferred tax liabilities 14 4,119 4,555

    27,297 31,814

    Current liabilities

    Trade and other payables 28 21,294 13,120

    Short-term borrowings 26 95,409 84,111

    Deferred income 27 128 -

    Derivative financial instruments 24 - 1,157

    Income tax liability 29 41 235

    Accruals 30 636 805

    117,508 99,428

    TOTAL EQUITY AND LIABILITIES 243,903 226,751

    Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015

    Huseyin Yorucu (signed)

    Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)

    Executive Directors Financial Director Chief Accountant

    Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)

    Managing Director, AndA Consulting Ltd. Registered Auditor

    March 4, 2015, Sofia

    The accompanying notes are an integral part of these financial statements.

  • АLCOMET AD

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 28

    CASH FLOW STATEMENT

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Cash flows from operating activities

    Profit before taxation 2,685 2,492

    Adjustments for:

    Depreciation of property, plant and equipment 11,619 9,820

    Amortization of intangible assets 200 161

    Loss on disposal of property, plant and equipment 6 -

    Carrying amount of obsolete property, plant and equipment 1 -

    Receivables and payables written-off, net 95 616

    Income from government grants (47) -

    Income from dealing with securities - (53)

    Interest expense, net 3,666 2,741

    Changes in accruals and retirement benefits obligation (428) (148)

    Exchange rate loss 136 106

    17,933 15,735

    Increase in inventory (13,706) (7,079)

    Increase in current accounts receivable (5,119) (5,244)

    Increase/(decrease) in current liabilities 8,170 (1,818)

    Cash, generated from operating activities

    7,278 1,594

    Interest received 8 1

    Interest paid (4,114) (3,217)

    Income tax paid (884) (109)

    Dividends paid (559) (582)

    Net cash, (used in)/generated fromoperating activities 1,729 (2,313) Cash flows from investing activities

    Purchase of property, plant and equipment and intangible assets (5,427) (9,987) Government grants 2,057 - Proceeds from sales of property, plant and equipment 21 -

    Net cash used in investing activities (3,349) (9,987) Cash flows from financing activities

    Proceeds from borrowings 698,323 650,852

    Repayments of borrowings (689,704) (635,686)

    Payments of finance lease obligations (2,835) (2,695) Net cash, generated from financing activities 5,784 12,471

    Net increase in cash and cash equivalents 4,164 171

    Cash and cash equivalents at the beginning of the period 509 338

    Cash and cash equivalents at the end of the period (see note 22) 4,673 509

    Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015

    Huseyin Yorucu (signed)

    Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)

    Executive Directors Financial Director Chief Accountant

    Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)

    Managing Director Registered Auditor

    AndA Consulting Ltd

    March 4, 2015, Sofia

    The accompanying notes are an integral part of these financial statements.

  • АLCOMET AD

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 29

    STATEMENT OF CHANGES IN EQUITY

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    Share

    capital Reserves

    Accumulated

    profit Total

    Balance at December 31, 2012 17,953 57,278 19,876 95,107

    Changes in equity for 2013

    Dividends - - (583) (583)

    Comprehensive income for the

    period - (1,253) 2,238 985

    Balance at December 31, 2013 17,953 56,025 21,531 95,509

    Changes in equity for 2014

    Dividends - - (560) (560)

    Revaluation reserve of obsolete

    property, plant and equipment - (315) 315 -

    Comprehensive income for the

    period - 1,742 2,407 4,149

    Balance at December 31, 2014 17,953 57,452 23,693 99,098

    Approved for issuance by the Managing Board of Alcomet AD on March 4, 2015

    Huseyin Yorucu (signed)

    Huseyin Umut Ince (signed) Semih Baturay (signed) Vencislav Petrov (signed)

    Executive Directors Financial Director Chief Accountant

    Antoaneta Bazlyankova (signed) Nadezhda Peeva-Uzunova (signed)

    Managing Director Registered Auditor

    AndA Consulting Ltd

    March 4, 2015, Sofia

    The accompanying notes are an integral part of these financial statements.

  • АLCOMET AD

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 30

    NOTES TO THE FINANCIAL STATEMENTS

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    1 General information

    1.1 Organization

    Alcomet AD (the Company) is a joint-stock company registered in Bulgaria in 1991. The Company

    is entered in the Trade Register of the Registry Agency under Unified Identification Code

    837066358. The address of the Company’s principal place of business and head office is Shumen,

    Second Industrial Zone.

    Alcomet AD is a public company, registered in the Public Companies Register, as per decision of

    the Financial Supervision Commission dated July 1, 1998. The Company’s shares are traded on the

    Bulgarian Stock Exchange, Sofia.

    The Company was established under the name of Alumina EAD and the sole shareholder of the

    Company was the Government of Bulgaria. On September 13, 1999 the Privatization Agency sold

    1,116,361 shares of the Company to private investors, which presented 75 % of the share capital of

    the Company.

    As of December 31, 2014 and 2013 the structure of the share capital of the Company is as follows:

    December 31,

    2014

    December 31,

    2013

    Alumetal AD 73.25% 73.25%

    FAF Metal Sanayj Ve Ticaret AS, Turkey 16.86% 16.86%

    ZUPF Allianz Bulgaria 3.59% 2.94%

    Other 6.30% 6.95%

    Total 100.00% 100.00%

    1.2 Operations

    The main operations of the Company include production and sale of castings, rolled and extruded

    aluminum products, used in machine building, construction, food industry, etc. The Company is the

    leading Bulgarian producer of aluminum products and one of the largest manufacturers on the

    Balkans. The plant is unique in Bulgaria as it includes entire production cycle and by the modern

    technological equipment of the three main workshops - casting, rolling and extrusion, produces a

    wide range of rolled and extruded products, which technical parameters and quality conform to the

    international standards ISO 9001:2008, ISO 14000:2004, OHSAS 18000:2007, AA , EN, DIN, BDS.

    The annual production capacity of the casting workshop is 78 thousand tons, rolling workshop -

    50 thousand tons and extrusion workshop - 23 thousand tons.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 31

    2 Basis for preparation of the financial statements

    2.1 Financial reporting framework

    The Company prepares and presents its financial statements in accordance with the International

    Financial Reporting Standards (IFRS), issued by the International Accounting Standards Board

    (IASB) and the Interpretations, issued by the International Financial Reporting Interpretations

    Committee (IFRIC), adopted by the European Union Commission (the Commission).

    During the current year the Company has adopted all new and revised standards and interpretations

    issued by the International Accounting Standards Board (IASB), effective for 2014 and applicable for

    the activities of the Company. All changes in IFRS, effective for 2014, are approved by the

    Commission (see note 2.1.1).

    These financial statements are prepared for general purpose and provide information for the financial

    position, results and cash flows, generated by the Company for the year ended December 31, 2014.

    2.1.1 Standards and Interpretations effective in the current period

    The following amendments to the existing standards and interpretations are adopted by the EU

    Comission and are effective for 2014:

    Standard or interpretation, date of

    revision and effective date

    Name of the standard or

    interpretation

    Effect on the Company’s

    activity

    Transition guidance (Amendments to

    IFRS 10, IFRS 11 and IFRS 12), issued

    in June 2012, effective for annual

    periods beginning on or after

    January 1, 2014

    Transition guidance No effect on the Company’s

    financial statements

    IFRS 10, issued in May 2011, effective

    for annual periods beginning on or after

    January 1, 2013, but applied in the EU

    after January 1, 2014

    Consolidated Financial Statements No effect on the Company’s

    financial statements

    IFRS 11, issued in May 2011, effective

    for annual periods beginning on or after

    January 1, 2013, but applied in the EU

    after January 1, 2014

    Joint Arrangements No effect on the Company’s

    financial statements

    IFRS 12, issued in May 2011, effective

    for annual periods beginning on or after

    January 1, 2013, but applied in the EU

    after January 1, 2014

    Disclosure of Interests in Other

    Entities

    No effect on the Company’s

    financial statements

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 32

    2 Basis for preparation of the financial statements (continued)

    2.1 Financial reporting framework (continued)

    2.1.1 Standards and Interpretations effective in the current period (continued)

    Standard or interpretation, date of

    revision and effective date

    Name of the standard or

    interpretation

    Effect on the Company’s

    activity

    IAS 27, issued in May 2011, effective

    for annual periods beginning on or after

    January 1, 2013, but applied in the EU

    after January 1, 2014

    Separate Financial Statements No effect on the Company’s

    financial statements

    IAS 28, issued in May 2011, effective

    for annual periods beginning on or after

    January 1, 2013, but applied in the EU

    after January 1, 2014

    Investments in Associates and Joint

    Ventures

    No effect on the Company’s

    financial statements

    Amendments to IAS 32, issued in

    December 2011, effective for annual

    periods beginning on or after

    January 1, 2014

    Financial Instruments: Presentation

    — Amendments to application

    guidance on the offsetting of

    financial assets and financial

    liabilities

    No effect on the Company’s

    financial statements

    Amendments to IFRS 10, IFRS 12 and

    IAS 27, issued in October 2012,

    effective for annual periods beginning on

    or after January 1, 2014

    Amendments to IFRS 10, IFRS 12

    and IAS 27: Investment entities

    No effect on the Company’s

    financial statements

    Amendments of IAS 36, issued on May

    29, 2013, effective for annual periods

    beginning on or after January 1, 2014

    Amendments to IAS 36, related to

    recoverable amount disclosures of

    non-financial assets

    No effect on the Company’s

    financial statements

    Amendments of IAS 39, issued on June

    27, 2013, effective for annual periods

    beginning on or after January 1, 2014

    Amendments of IAS 39, related to

    novation of derivatives and

    continuation of hedge accounting

    No effect on the Company’s

    financial statements

    IFRIC interpretation 21 Levies, issued on

    May 20, 2013, effective for annual

    periods beginning on or after January 1,

    2014

    IFRIC interpretation No effect on the Company’s

    financial statements

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 33

    2 Basis for preparation of the financial statements (continued)

    2.1 Financial reporting framework (continued)

    2.1.2 Standards and Interpretations, issued by the International Accounting Standards Board (IASB),

    adopted by the Commission, not yet effective

    Standard or interpretation, date of

    revision and effective date

    Name of the standard or

    interpretation

    Date of adoption

    by the EU Commission

    Annual Improvements 2010-2012

    Cycle, issued by the IASB on

    December 12, 2013, applicable to

    annual periods beginning on or after

    July 1, 2014

    Improvements to IFRS

    (IFRS 2, IFRS 3, IFRS 8, IFRS

    13, IAS 16, IAS 24 and

    IAS 38)

    December 17, 2014

    Annual Improvements 2011-2013

    Cycle, issued by the IASB on

    December 12, 2013, applicable to

    annual periods beginning on or after

    July 1, 2014

    Improvements to IFRS

    (IFRS 1, IFRS 3, IFRS 13 and

    IAS 40)

    December 18, 2014

    Defined Benefit Plans: Employee

    Contributions issued on November 21,

    2013, effective for annual periods

    beginning on or after July 1, 2014

    Amendments to IAS 19 December 17, 2014

    2.1.3 Standards and Interpretations, issued by the IASB, expected endorsement by the EU Commission

    Standard or interpretation, date of

    revision and effective date

    Name of the standard or

    interpretation

    Status of adoption

    by the EU Commission

    IFRS 9 Financial Instruments (issued on

    July 24, 2014), effective for annual

    periods beginning on or after

    January 1, 2018

    Financial Instruments –

    Classification and Measurement,

    the standard will supersede

    completely IAS 39

    Endorsement expected in

    the second half of 2015

    IFRS 14, issued in January, 2014,

    effective for annual periods beginning on

    or after January 1, 2016

    Regulatory Deferral Accounts -

    applicable to an entity's first annual

    IFRS financial statements for a

    period beginning on or after

    January 1, 2016

    The endorsement date is yet

    to be determined

    IFRS 15, issued in May, 2014, effective

    for annual periods beginning on or after

    January 1, 2017

    Revenue from Contracts with

    Customers - applicable to an

    entity's first annual IFRS financial

    statements for a period

    beginning on or after

    January 1, 2017

    Endorsement is expected

    in Q 2 2015

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 34

    2 Basis for preparation of the financial statements (continued)

    2.1 Financial reporting framework (continued)

    2.1.3 Standards and Interpretations, issued by the IASB, expected endorsement by the EU Commission

    (continued)

    Standard or interpretation, date of

    revision and effective date

    Name of the standard or

    interpretation

    Status of adoption

    by the EU Commission

    Amendments to IFRS 10, IFRS 12 and

    IAS 28 (issued on December 18,

    2014), effective for annual periods

    beginning on or after January 1, 2016

    Investment Entities: Applying the

    Consolidation Exception

    Endorsement is expected

    in Q 4 2015

    Amendments to IAS 1 (issued on

    December 18, 2014), effective for

    annual periods beginning on or after

    January 1, 2016

    Disclosure Initiative Endorsement is expected

    in Q 4 2015

    Annual Improvements 2012-2014

    Cycle, issued by the IASB on

    September 25, 2014, applicable to

    annual periods beginning on or after

    January 1, 2017

    Improvements to IFRS

    (IFRS 5, IFRS 7, IAS 19 and IAS

    34)

    Endorsement is expected

    in Q 3 2015

    Amendments to IFRS 10 and IAS 28,

    issued on September 11, 2014,

    effective for annual periods beginning

    on or after January 1, 2016

    Amendments to IFRS 10 and IAS

    28: Sale or Contribution of Assets

    between an Investor and its

    Associate or Joint Venture

    Endorsement is expected

    in Q 4 2015

    Amendments to IAS 27, issued on

    August 12, 2014, effective for annual

    periods beginning on or after

    January 1, 2016

    Amendments to IAS 27: Equity

    Method in Separate Financial

    Statements

    Endorsement is expected

    in Q 3 2015

    Amendments to IAS 16 and IAS 41,

    issued on June 30, 2014, effective for

    annual periods beginning on or after

    January 1, 2016

    Amendments to IAS 16 and IAS

    41: Bearer Plants

    Endorsement is expected

    in Q 1 2015

    Amendments to IAS 16 and IAS 38,

    issued on May 12, 2014, effective for

    annual periods beginning on or after

    January 1, 2016

    Amendments to IAS 16 and IAS

    38: Clarification of Acceptable

    Methods of Depreciation and

    Amortization

    Endorsement is expected

    in Q 1 2015

    Amendments to IFRS 11, issued on

    May 6, 2014, effective for annual

    periods beginning on or after

    January 1, 2016

    Amendments to IFRS 11:

    Accounting for Acquisitions of

    Interests in Joint Operations

    Endorsement is expected

    in Q 1 2015

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 35

    2 Basis for preparation of the financial statements (continued)

    2.1 Financial reporting framework (continued)

    2.1.4 Impact of the new and revised standards on the financial statements

    In the current year, the Company has applied a number of amendments to IFRSs and a new

    Interpretation issued by the International Accounting Standards Board (IASB) that are mandatorily

    effective for an accounting period that begins on or after 1 January 2014.

    The more significant changes in the accounting standards are, as follows:

    IFRS 10 Consolidated Financial Statements

    The objective of IFRS 10 is to establish principles for the presentation and preparation of consolidated

    financial statements when an entity controls one or more other entities. IFRS 10 is a replacement of

    IAS 27 Consolidated and Separate Financial Statements and SIC-12 Consolidation – Special Purpose

    Entities. Concurrent with the issuance of IFRS 10, the IASB also issued:

    IFRS 11 Joint Arrangements;

    IFRS 12 Disclosure of Interests in Other Entities;

    IAS 27 Separate Financial Statements (reissued in 2011), and

    IAS 28 Investments in Associates and Joint Ventures (reissued in 2011).

    These amendments do not affect the Company, as it does not prepare consolidated financial

    statements (see also noe 19) and has no any and not planned undertaking of engagements for joint

    ventures.

    Amendments to IFRS 10, IFRS 12 and IAS 27 Investment Entities

    The Company has applied the amendments to IFRS 10, IFRS 12 and IAS 27 regarding investment

    entities for the first time in the current year. The amendments to IFRS 10 define an Investment entity

    and require a reporting entity that meets the definition of an Investment entity not to consolidate its

    subsidiaries but instead to measure its subsidiaries at fair value through profit or loss in its

    consolidated and separate financial statements.

    To qualify as an “investment entity”, a reporting entity is required to:(i) obtain funds from one or

    more investors for the purpose of providing them with investment management services; (ii) commit

    to its investor(s) that its business purpose is to invest funds solely for returns from capital

    appreciation, investment income, or both; and (iii) measure and evaluate performance of substantially

    all of its investments on a fair value basis.

    http://www.iasplus.com/standard/ifrs11.htmhttp://www.iasplus.com/standard/ifrs12.htmhttp://www.iasplus.com/standard/ias28_2011.htm

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 36

    2 Basis for preparation of the financial statements (continued)

    2.1 Financial reporting framework (continued)

    2.1.4 Impact of the new and revised standards on the financial statements (continued)

    Amendments to IFRS 10, IFRS 12 and IAS 27 Investment Entities (continued)

    Consequential amendments have been made to IFRS 12 and IAS 27 to introduce new disclosure

    requirements for Investment entitles.

    As the Company is not an investment entity (assessed based on the criteria set out in IFRS 10 as at

    January 1, 2014), the application of the amendments has had no impact on the disclosures or the

    amounts recognised in the Company’s financial statements.

    Amendments to IAS 32 Offsetting Financial Assets and Financial Liabilities

    The Company has applied the amendments to IAS 32 regarding offsetting financial assets and

    financial liabilities for the first time in the current year. The amendments to IAS 32 clarify the

    requirements relating to the offset of financial assets and financial liabilities. Specifically, the

    amendments clarify the meaning of “currently has a legally enforceable right of set-off” and

    “simultaneous realisation and settlement”.

    The amendments have been applied retrospectively. As the Company does not have any financial

    assets and financial liabilities that qualify for offset, the application of the amendments has had no

    impact on the disclosures or on the amounts recognised in the Company’s financial statements.

    Amendments to IAS 36 Recoverable Amount Disclosures for Non-financial Assets

    The Company has applied the amendments to IAS 36 regarding recoverable amount disclosures for

    non-financial assets for the first time in the current year. The amendments to IAS 36 remove the

    requirement to disclose the recoverable amount of a cash-generating unit (CGU) to which goodwill or

    other intangible assets with indefinite useful lives had been allocated when there has been no

    impairment or reversal of impairment of the related CGU.

    Furthermore, the amendments introduce additional disclosure requirements applicable to when the

    recoverable amount of an asset or a CGU is measured at fair value less costs of disposal. These new

    disclosures include the fair value hierarchy, key assumptions and valuation techniques used which are

    in line with the disclosure required by IFRS 13 Fair Value Measurements.

    The application of these amendments has had no material impact on the disclosures in the Company’s

    financial statements.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 37

    2 Basis for preparation of the financial statements (continued)

    2.1 Financial reporting framework (continued)

    2.1.4 Impact of the new and revised standards on the financial statements (continued)

    Amendments to IAS 39 Novation of Derivatives and Continuation of Hedge Accounting

    The Company has applied the amendments to IAS 39 regarding novation of derivatives and

    continuation of hedge accounting for the first time in the current year. The amendments to IAS 39

    provide relief from the requirement to discontinue hedge accounting when a derivative designated as a

    hedging instrument is novated under certain circumstances. The amendments also clarify that any

    change to the fair value of the derivative designated as a hedging instrument arising from the novation

    should be included in the assessment and measurement of hedge effectiveness.

    The amendments have been applied retrospectively. As the Company does not have any derivatives

    that are subject to novation, the application of these amendments has had no impact on the disclosures

    or on the amounts recognised in the Company’s financial statements.

    IFRIC 21 Levies

    The Company has applied IFRIC 21 Levies for the first time in the current year. IFRIC 21 addresses

    the issue as to when to recognise a liability to pay a levy imposed by a government. The interpretation

    defines a levy, and specifies that the obligating event that gives rise to the liability is the activity that

    triggers the payment of the levy, as identified by legislation. The interpretation provides guidance on

    how different levy arrangements should be accounted for, in particular, it clarifies that neither

    economic compulsion nor the going concern basis of financial statements preparation implies that an

    entity has a present obligation to pay a levy that will be triggered by operating in a future period.

    IFRIC 21 has been applied retrospectively. The application of this Interpretation has had no material

    impact on the disclosures or on the amounts recognised in the Company’s financial statements.

    During 2014 the Company has not elected early adoption of standards, revisions and interpretations,

    effective for future annual periods. The Company anticipates that the adoption of the standards,

    amendments to the existing standards and interpretations would have no material impact on its

    financial statements in the period of initial application, except for IFRS 9, the impact of which has not

    yet been evaluated.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 38

    2. Basis for preparation of the financial statements (continued)

    2.2 Historical cost and fair value

    The present financial statements have been prepared on the historical cost basis except for certain

    property, plant and equipment, investment property and derivative financial instruments that are

    measured at revalued amounts or fair values, as explained in notes 3.7, 3.9 and 3.12 below.

    Historical cost is generally based on the fair value of the consideration given in exchange for goods

    and services.

    Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly

    transaction between market participants at the measurement date, regardless of whether that price is

    directly observable or estimated using another valuation technique. In estimating the fair value of an

    asset or a liability, the Company takes into account the characteristics of the asset or liability if market

    participants would take those characteristics into account when pricing the asset or liability at the

    measurement date. Fair value for measurement and/or disclosure purposes in these financial

    statements is determined on such a basis, except for share-based payment transactions that are within

    the scope of IFRS 2, leasing transactions that are within the scope of IAS 17, and measurements that

    have some similarities to fair value but are not fair value, such as net realizable value in IAS 2 or

    value use in IAS 36.

    In addition, for the financial reporting purposes, fair value measurements are categorized into Level 1,

    2 or 3 based on the degree to which the inputs to the fair value measurements are observable and the

    significance of the inputs to the fair value measurement in its entirely, which are described as follows:

    - Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities

    that the Company can access at the measurement date;

    - Level 2 inputs are inputs, other than quoted prices included within Level 1, that are observable

    for the asset or liability, either directly or indirectly;

    - Level 3 inputs are unobservable inputs for the asset or liability.

    2.3 Functional and presentation currency

    Functional currency is the currency of the primary economic environment, in which an entity operates

    and in which it generates and expends cash. The entity carries out its transactions mainly in Bulgarian

    Lev, and for this reason the functional and presentation currency is the Bulgarian Lev, which since

    January 1, 1999 has been pegged to the EURO at a fixed exchange rate of EUR 1: BGN 1.95583.

    These financial statements are presented in thousands of BGN.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 39

    3 Significant accounting policies

    3.1 Revenue and expense recognition

    Revenue is measured at the fair value of the consideration received or receivable and represents

    amounts receivable for goods and services provided in the normal course of business, net of discounts,

    Value Added Tax (VAT) and other sales related taxes.

    Revenue is recognized when the entity has transferred all risks and rewards related to the ownership

    of the production and goods to the buyer and the costs incurred in respect of the transaction can be

    measured reliably.

    Expenses are recognized in the income statement when a decrease of the future economic benefits

    arise, regarding decrease of an asset or increase of a liability, which can be reliably measured.

    Expenses are recognized on the basis of a direct association between the costs incurred and the revenue.

    When economic benefits are expected to incur during more than one financial period and the

    corresponding revenue cannot be measured precisely but only indirectly, the expenses shall be

    recognized based on procedures for rational and systematic allocation.

    Income from government grants related to assets is recognized in profit or loss on a systematic basis

    over the whole useful lives of the related assets (see also note 3.14).

    3.2 Interest income

    Interest income is accrued on a time basis, based on the outstanding principal and the applicable

    effective interest rate, which is the rate that exactly discounts estimated future cash receipts through

    the expected life of the financial asset to the net carrying amount of the asset.

    3.3 Borrowing costs

    Borrowing costs are recognized in the period in which they are incurred and are determined on the

    basis of the outstanding principal and the applicable effective interest rate, which is the rate that

    exactly discounts estimated future cash payments through the expected life of the financial liability to

    the net carrying amount of the liability.

    Borrowing costs that are directly attributable to the acquisition, construction or production of an asset,

    that takes a substantial period of time to get ready for its intended use or sale, are capitalized as part of

    the cost of the asset in accordance with the requirements of IAS 23 Borrowing costs. The borrowing

    costs that are directly attributable to the acquisition or production of a qualifying asset are those

    borrowing costs that would have been avoided, if the expenditure on the qualifying asset had not been

    made.

    The amount of borrowing costs eligible for capitalization is determined as the actual borrowing costs

    incurred on the borrowings during the period less any investment income on the temporary investment

    of those borrowings. To the extent that funds are borrowed generally and used for the purpose of

    obtaining a qualifying asset, the amount of borrowing costs eligible for capitalization is determined by

    applying a capitalization rate to the expenditures on that asset. The capitalization rate is the weighted

    average of the borrowing costs applicable to the borrowings that are outstanding during the period.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 40

    3 Significant accounting policies (continued)

    3.3 Borrowing costs (continued)

    Investment income earned on the temporary investment of specific borrowings pending their

    expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalization. All

    other borrowing costs are recognized in profit or loss in the period in which they are incurred.

    Capitalization of borrowing costs ceases when substantially all the activities necessary to prepare the

    qualifying asset for its intended use are complete.

    3.4 Foreign currency

    Foreign currency transactions are recorded at the rates of exchange prevailing on the dates of the

    transactions. At the end of each reporting period, monetary assets and liabilities that are denominated

    in foreign currencies are retranslated at the closing exchange rates of the Bulgarian National Bank.

    The foreign exchange rate differences, arising upon the settlement of these monetary positions or at

    restatement of these positions at rates, different from those when initially recorded, are reported as

    current financial income or current financial expense in the period in which they arise.

    3.5 Employee benefits

    Short-term employee benefits

    Labor and social relationships between the employees and the Company are arranged under the

    provisions of the Labour Code (LC) and the social security legislation requirements enforceable in the

    Republic of Bulgaria.

    Short-term employee benefits including remunerations, bonuses and social payments and benefits

    (payable within 12 months after the period in which employees have rendered their service or satisfied

    the necessary conditions) are recognized as an expense in the income statement for the period in

    which the service is rendered or the vesting conditions are met, and as a current liability (after

    reduction of any amounts paid and deductions) to its undiscounted amount. The Company’s

    contributions for social security and health insurance are recognized at their undiscounted amount as

    current expense and liability together with and for the period, when the respective employee benefits

    are accrued.

    Unused paid annual leaves accruals

    As of the reporting period end, the Company recognizes as a liability the non-discounted amount of

    the estimated expenses on paid leaves, expected to be paid to employees during following reporting

    periods as compensation to their labor in the previous reporting period, as well as the respective to

    these accruals expenses on social security contributions.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 41

    3 Significant accounting policies (continued)

    3.5 Employee benefits (continued)

    Long-term employee benefits

    Defined contributions plan

    The Bulgarian government has responsibility to ensure retirement benefits based on definite

    contributions. Expenses, concerning the Company’s responsibility to transfer installments on the

    definite contributions plan, are recognized in the income statement for the period in which they arise.

    Additionally, the Company takes part in a defined contributions plan, which is a retirement plan. The

    Company pays additional defined contributions to an independent company (pension fund) in favor of

    the employees, included in the plan and has no legal or constructive obligation to pay additional

    contributions in case the fund has insufficient assets to pay all employees the compensations,

    regarding their length of service from the current or previous periods. The Company’s contributions

    for this definite contributions plan are reported in the income statement for the respective period and

    are included in employee benefits.

    Defined benefits plan

    Under the provisions of the Labor Code, the employees are entitled to retirement benefits amounting

    to two gross monthly salaries on attainment of retirement age if the accumulated length of service in

    the Company is under 10 years, or six gross monthly salaries if the length of service in the Company

    is over 10 consecutive years.

    Additionally, on early retirement due to disability, the employees are entitled to benefits amounting to

    two monthly salaries, provided that their length of service is at least five years, and they have received

    no other such benefits during the last five years of service. Based on the Company’s Collective Labor

    Agreement dated 2006, the employees that due to disease are disabled to perform the work assigned

    and in case of length of service over ten consecutive years, are entitled to an additional benefit from

    the Company, amounting to one minimal monthly salary determined for the country.

    In accordance with requirements of IAS 19 Employee benefits, the Company recognizes a retirement

    benefits liability, which is determined estimated by a licensed actuary using the Projected Unit Credit

    Method. The retirement benefits liability presents the present value of the defined retirement benefits

    liability as of the date of the statement of financial position. The present value of the defined liability

    is estimated based on the expected future cash outflows, using the interest rate of the government

    bonds, which have a maturity term similar to the maturity of the respective liability.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 42

    3 Significant accounting policies (continued)

    3.5 Employee benefits (continued)

    Defined benefits plan (continued)

    By the use of the Projected Unit Credit Method:

    • is determined what portion of the benefits is attributable to the current period and the portion

    for previous periods, and estimates are made (actuarial assumptions) about demographic

    variables (such as employee turnover and mortality of employees) and financial variables (such

    as future increases in salaries and expenses on medical services) that will affect the cost of the

    benefits;

    • so defined benefits are discounted to determine the present value of the obligation for defined

    benefits and the expenses for current service cost;

    The current and past service costs and the interest on the liability of the defined benefits plan are

    recognized in profit or loss for the period.

    Revaluations of liabilities on the defined benefits plan (actuarial gain or loss) are recognized through

    other comprehensive income in equity as a reserve for retirement benefits liabilities. Released from

    this reserve amounts are transferred through other comprehensive income to retained earnings.

    Pension costs are charged or reflected in profit or loss for the period of service of the respective

    employees. Past service costs are recognized immediately to the extent that the benefits are already

    vested.

    The amount of the retirement benefits obligation, reported in the statement of the financial position

    represents the present value of the defined benefits obligation of the Company.

    3.6 Taxation

    According to the Bulgarian tax legislation, the Company is subject to corporate income tax. The

    corporate income tax rate for 2014 and 2013 is 10 % on the taxable profit.

    Income tax expense represents the sum of the tax currently payable and deferred tax.

    The tax currently payable is based on the taxable profit for the year. Taxable profit differs from profit

    before taxes as reported in the income statement because it excludes items of income or expenses that

    are taxable or deductible in other years and it further excludes items that are never taxable or

    deductible. The Company’s liability for current tax is calculated using tax rates that have been enacted

    by the end of the reporting period.

    Deferred tax is the tax expected to be payable or recoverable on differences between the carrying

    amounts of assets and liabilities in the financial statements and the corresponding tax bases used in

    the computation of taxable profit, and is accounted for using the balance sheet liability method.

    Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax

    assets are recognized to the extent that it is probable that taxable profits will be available, against

    which deductible temporary differences can be utilized.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 43

    3 Significant accounting policies (continued)

    3.6 Taxation (continued)

    The carrying amount of deferred tax assets is reviewed at the end of each year and reduced to the

    extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of

    the asset to be recovered.

    Furthermore at the end of each reporting period deferred tax assets not-recognized in previous

    reporting periods are reviewed. Such assets are recognized to the extent that it is probable to generate

    sufficient taxable profit in future, against which the deferred tax assets to be recovered.

    Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is

    settled or the asset realized. Deferred tax is recognized charged or credited in the income statement,

    except when it relates to items charged or credited directly to equity, in which case the deferred tax is

    also dealt with in equity.

    Deferred tax assets and liabilities are offset when they relate to income taxes levied by the same

    taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

    3.7 Property, plant and equipment

    Property, plant and equipment are initially carried at cost, including purchase cost and any related

    costs, less any subsequently accumulated depreciation and any impairment losses.

    After initial recognition, land, buildings, plants and equipment are stated at their revalued amounts,

    being the fair value at the date of revaluation, less any subsequent accumulated depreciation and

    subsequent accumulated impairment losses. Revaluations are performed by licensed appraisers with

    sufficient regularity so that the carrying amounts do not differ materially from that which would be

    determined using fair values at the end of each reporting period.

    Increases in the carrying amount of assets as a result of the revaluation are credited directly to equity

    as a revaluation surplus. Decreases in carrying amounts of assets as a result of the revaluation are

    recognized as expenses. However, a revaluation decrease is debited directly to revaluation reserve to

    the extent that the decrease does not exceed the amount held in the revaluation surplus in respect of

    those assets. The accumulated depreciation of revalued assets at the date of the revaluation is restated

    proportionally with the change in the gross carrying amount of the assets, so that the carrying amount

    of the assets after the revaluation equals the revalued amount.

    On subsequent disposal of a revalued property, plant and equipment the attributable revaluation

    surplus remaining in the revaluation reserve is transferred to retained earnings, net of deferred taxes.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 44

    3 Significant accounting policies (continued)

    3.7 Property, plant and equipment (continued)

    At the end of each reporting period, the management of the Company reviews the carrying amounts of

    property, plant and equipment, which have not been valuated by a licenced appraiser and determines

    whether there is any indication for impairment of these assets.

    Land and buildings, which are held to earn rentals are presented as investment property (see also note

    3.9 and note 18).

    The depreciation charge starts after putting the respective assets into operation and commences on the

    earlier of their date of reclassification as held for sale, as required by IFRS 5 Non-current assets held

    for sale and discontinued operations and their date of disposal.

    Depreciation of property, plant and equipment is charged over their estimated useful lives under the

    straight-line method. The estimated useful lives of the assets in years are, as follows:

    2014 2013

    Buildings 25 - 30 25 - 30

    Plant and equipment 5 - 17 5 - 17

    Vehicles 10 10

    Office equipment 6-7 6-7

    Other non-current assets 5 5

    Assets held under finance leases are depreciated over their expected useful lives on the same basis as

    owned assets. However, when there is no reasonable certainty that ownership will be obtained by the

    end of the lease term, assets are depreciated over the shorter of the lease term and their useful lives.

    Depreciation is not provided for land, fully depreciated assets and assets in process of acquisition or

    construction.

    Assets are derecognized upon disposal or when no future economic benefits are expected to arise from

    the continued use of the asset. The gain or loss arising on the disposal or retirement of an asset is

    determined as the difference between the sales proceeds and the carrying amount of the asset and is

    recognized in the income statement.

    3.8 Intangible assets

    Intangible assets are carried at cost less accumulated amortization and any subsequent impairment

    losses.

    Amortization of intangible assets is charged over their estimated useful lives, under the straight-line

    method, which period is from 2 to 7 years.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 45

    3 Significant accounting policies (continued)

    3.8 Intangible assets (continued)

    European Union Emissions Trading Scheme and emission reduction units of greenhouse gases

    The EU Allowances (EUA), received under the National Plan for allocation of allowances for trade

    with emissions of greenhouse gases, are reported as intangible assets. Upon their initial acquisition,

    the allocated allowances for emissions of greenhouse gases are recognized as intangible assets at

    nominal value (zero value). The purchased allowances are recognized upon their acquisition at

    purchase price. The allowances for emissions of greenhouse gases are not depreciated.

    As at the end of each reporting period, for the amount of greenhouse gases emitted during the period

    over the available distributed and purchased allowances, the Company recognizes a liability in the

    statement of financial position. The liability is valued at cost of the allowances purchased, used to

    cover the excess and on market prices as at the date of the statement of financial position for the

    excess over the available allowances, as the liability amount and the changes therein are recognized in

    profit or loss for the reporting period.

    3.9 Investment property

    Investment property is property held to earn rentals and is carried at fair value. As a part of property,

    plant and equipment of the Company, investment properties are revaluated to their fair value by

    licensed appraisers to the date of their classification as investment property. If an asset’s carrying

    amount is increased as a result of such revaluation, the increase is credited directly to equity as

    revaluation surplus.

    The revaluation decrease is recognized in the income statement or is debited directly to equity as

    revaluation surplus to the extent of any credit balance existing in the revaluation surplus in respect of

    that asset. After transfer of assets to investment property, subsequent gains or losses from changes in

    fair value are recognized in the net profit for the period when they arise.

    An investment property is derecognized upon disposal or when the investment property is

    permanently withdrawn from use and no future economic benefits are expected from the disposal.

    Any gain or loss arising on derecognition of the property is calculated as the difference between the

    disposal proceeds and the carrying amount of the asset and is included in the income statement.

    Rental income from operating leases is recognised on a straight-line basis over the term of the relevant

    lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the

    carrying amount of the leased asset and recognised on a straight-line basis over the lease term.

    3.10 Impairment of property, plant and equipment, intangible assets and investment property

    At the end of the reporting period, the Company reviews the carrying amounts of its property, plant

    and equipment, intangible assets and investment property to determine whether there is any indication

    of impairment. If any such indication exists, the recoverable amount of the asset is estimated in order

    to determine the extent of the impairment loss. Where the recoverable amount of an asset cannot be

    reliably measured, the Company estimates the recoverable amount of the cash-generating unit, to

    which the asset belongs.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 46

    3 Significant accounting policies (continued)

    3.10 Impairment of property, plant and equipment, intangible assets and investment property

    (continued)

    Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in

    use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate

    that reflects current market assessments of the time value of money and the risks specific to the asset

    for which the estimates of future cash flows have not been adjusted.

    If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying

    amount, the carrying amount of the asset (cash-generating unit) is reduced to its recoverable amount.

    The impairment loss is recognized as expense immediately, unless the relevant asset is carried at a

    revalued amount, in which case the impairment loss is treated as a revaluation decrease.

    When an impairment loss is subsequently reversed, the carrying amount of the asset (cash-generating

    unit) is increased to the revised estimate of its recoverable amount, so that the increased carrying

    amount does not exceed the carrying amount that would have been determined, had no impairment

    loss been recognized for the asset (cash-generating unit) in prior years. A reversal of an impairment

    loss is recognized as income immediately, unless the relevant asset is carried at a revalued amount, in

    which case the reversal of the impairment loss is treated as a revaluation increase.

    3.11 Inventories

    Inventories are valued at the lower of cost and net realizable value. Cost comprises of all costs of

    purchase, transportation, customs duties and other related costs.

    Net realizable value represents the estimated selling price less all estimated costs of completion and

    costs to sell.

    The costs of conversion of inventories include costs directly attributable to the units of production.

    They also include a systematic allocation of fixed and variable production overheads that are incurred

    in converting materials into finished goods. The costs of conversion of each product, which are not

    separately identifiable, are allocated between the products on a rational and consistent basis.

    Assignment of the cost is determined on a weighted average basis.

    3.12 Financial instruments

    Financial assets and financial liabilities are recognized in the Company’s statement of financial

    position only when the Company becomes a party to the contractual provisions of the instrument.

    Financial assets are derecognized from the statement of financial position when the contractual rights

    to receive the cash flows from the financial asset expire, or the assets are transferred and the transfer

    qualifies for derecognition in accordance with the derecognition requirements of IAS 39 Financial

    Instruments: Recognition and Measurement. Financial liabilities are derecognized from the statement

    of financial position only when they are extinguished – i.e. when the obligation specified in the

    contract is discharged or cancelled, or expired.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 47

    3 Significant accounting policies (continued)

    3.12 Financial instruments (continued)

    On initial recognition financial assets/(liabilities) are measured at fair value plus, in the case of

    financial assets/(liabilities) not reported at fair value through profit or loss, transaction costs, which

    are directly attributable to the acquisition or issue of the financial assets/(liabilities).

    For the purposes of subsequent measurement, in the current and prior reporting periods the Company

    classifies the financial assets and financial liabilities into the following categories: loans and

    receivables, and other financial liabilities (other than those, reported at fair value through profit or

    loss). The classification under each category depends on the purpose and term of the respective

    contract.

    Debt and equity instruments issued by the Company, are classified as either financial liabilities or as

    equity in accordance with the substance of the contractual arrangements and the definitions of a

    financial liability and an equity instrument. An equity instrument is any contract that evidences a

    residual interest in the assets of an entity after deducting all of its liabilities.

    Financial assets

    Financial assets comprise cash on hand and in bank accounts, investments, loans granted, trade and

    other receivables and derivative financial instruments.

    Financial liabilities

    Financial liabilities include trade and other payables, loans received, finance lease liabilities and

    derivative financial instruments.

    Effective interest rate

    The effective interest method is a method of calculating the amortized cost of a financial asset or a

    liability (or group of financial assets/liabilities) and of allocating the interest expense or interest

    income over the relevant period. The effective interest rate is the rate that exactly discounts the

    estimated future cash payments or receipts through the expected life of the financial instrument or,

    when appropriate, a shorter period to the net carrying amount of the financial asset or liability.

    Impairment of financial assets

    As of the date of the financial statements the Company assesses whether there is any objective

    evidence for impairment of all financial assets, except for financial assets reported at fair value

    through profit or loss. A financial asset is impaired if, and only if, there is objective evidence of

    impairment as a result of one or more events that have occurred after the initial recognition of the

    asset, resulting in a decrease of the estimated future cash flows. It may not be possible to identify a

    single, discrete event, rather than a combined effect of several events that may have caused the

    impairment.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 48

    3 Significant accounting policies (continued)

    3.12 Financial instruments (continued)

    Impairment of financial assets (continued)

    The Company recognizes impairment of trade and other receivables, whether there is objective

    evidence, that the Company would not be able to collect all amounts due at their maturity date. The

    Company considers as indications for potential impairment significant financial problems of the

    debtor, the probability that the debtor will be a subject to a bankruptcy procedure or non-fulfillment of

    the contract terms, as well as payment delay. If any of these indications for impairment occurs, the

    impairment loss is calculated as a difference between the carrying amount and the present value of the

    expected future cash flows, discounted by the original effective interest rate for similar assets. For

    trade receivables that are insured, the impairment equals the difference between the carrying amount

    of the receivables and their insurance value. The impairment is recorded by using a separate

    impairment account, which is shown as a reduction to receivables in the statement of financial

    position and the impairment expenses are stated as Administrative expenses or Distribution expenses

    in the income statement depending on the type of the impaired receivable. If a receivable is non-

    collectable and there is a recognized impairment loss for it, the receivable is written off by decrease of

    the respective allowance account. The recovery of the loss from impairment of trade receivables is

    reported in profit or loss and is stated as a decrease of the item, in which the impairment has been

    previously recorded.

    Derivative financial instruments

    The Company uses forward contracts to hedge risks, associated with changes in market prices of the

    aluminum on the London Metal Exchange. Such contracts are classified as cash flow hedges as they

    hedge the Company’s exposure to variability in cash flows that is attributable to the particular price

    risk associated with forecasted sale and purchase transactions. Derivatives are initially recognised at

    fair value at the date a derivative contract is entered into and are subsequently remeasured to their fair

    value at the end of each reporting period. The fair value of such forward contracts is determined by

    reference to the current prices of these contracts on the London Metal Exchange.

    The unrealized gain or loss on the forward contracts that are determined to be effective hedge is

    recognized through other comprehensive income and is accumulated in a hedging reserve. When a

    hedged transaction affects the net profit or loss, the unrealized gain or loss recognized beforehand in a

    hedging reserve, is included in the purchase price of the respective acquired inventory.

    The Company uses foreign currency swap contracts to hedge its risks associated with the changes in

    the foreign currency rates of a long-term debt, denominated in USD. These contracts are classified as

    fair value hedges and are initially recognized based on the fair value as of the contract date and

    subsequently remeasured to their fair value as of the end of the reporting period. The realized gains

    and losses, and the differences in fair value of the foreign currency swap contracts as at the end of the

    reporting period are charged in the income statement.

    Hedge accounting is discontinued when the hedging instrument expires or is sold, terminated or

    exercised.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 49

    3 Significant accounting policies (continued)

    3.12 Financial instruments (continued)

    3.12.1 Cash and cash equivalents

    For the purposes of cash flow presentation, cash and cash equivalents represent unrestricted cash on

    hand and at banks. For the purposes of the cash flow statement presentation cash receipts from

    customers and cash payments to suppliers are presented as gross amounts, including value added tax

    (VAT). VAT on purchase of property, plant and equipment and intangible assets is presented as

    payments to suppliers in the cash flows from operating activities.

    3.12.2 Equity investments and loans granted

    The equity investments are non-tradable and are stated at cost less any impairment loss.

    Long-term loans granted are initially carried at fair value and subsequently measured at amortized

    cost using effective interest rate, which, due to the substance of the loan agreement, coincides with the

    interest rate negotiated.

    3.12.3 Trade and other receivables

    Trade and other receivables are non-derivative financial assets with fixed or determinable payments

    that are not quoted in an active market. They are originated when the Company provides cash, goods

    for sale or services having no intention to trade them. Receivables are stated at amortized cost,

    calculated under the effective interest rate method. For current receivables, which will be settled

    within normal credit terms, the amortized cost approximates their nominal value.

    3.12.4 Trade and other payables

    Trade and other payables incurred as a result of purchases of goods or services, which are not

    classified as financial liabilities measured at fair value through profit or loss, are stated in the

    statement of financial position at amortized cost, calculated under the effective interest rate method.

    For current payables, which will be settled whithin normal credit terms, the amortized cost

    approximates their nominal value.

    3.12.5 Borrowings and leasing

    All borrowings are initially recognized at cost, being the fair value of the consideration received net of

    issue costs associated with the borrowing. After initial recognition, interest bearing loans and

    borrowings are subsequently measured at amortized cost using the effective interest rate method.

    Amortized cost is calculated by taking into account any issue costs, and any discount or premium on

    settlement. Gains and losses are recognized in the net profit or loss when the liabilities are

    derecognized or impaired, as well as through the amortization process.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 50

    3 Significant accounting policies (continued)

    3.12 Financial instruments (continued)

    3.12.5 Borrowings and leasing (continued)

    Leases are classified as finance leases whenever the terms of the lease transfer substantially all the

    risks and rewards of ownership to the lessee. All other leases are classified as operating leases.

    Assets held under finance leases are recognised as assets of the Company at the lower of the present

    value of the minimum lease payments and their fair value at the date of acquisition. The

    corresponding liability to the lessor is included in the statement of financial position as a finance lease

    obligation. Finance costs, which represent the difference between the total leasing commitments and

    the fair value of the assets acquired, are charged to the income statement over the term of the relevant

    lease so as to produce a constant periodic rate of charge on the remaining balance of the obligations

    for each accounting period.

    3.12.6 Interest rate risk

    Interest rate risk is the risk that the value of the Company’s borrowings will fluctuate due to changes

    in market interest rates. Part of the Company’s borrowings are contracted at a floating interest rate and

    thus expose the Company to eventual interest rate risk (see also notes 26 and 31).

    3.12.7 Credit risk

    Financial assets, which potentially expose the Company to credit risk, consist mainly of trade

    receivables and advance payments. The Company is primarily exposed to credit risk in the event

    where its customers fail to perform their obligations. The Company’s policy is to enter into sales

    transactions with customers having favorable credit reputation. In addition, the trade receivables are

    secured against future risks by credit limits, which are defined by the insurance company based on

    preliminary client research. The Company would receive 90 % of the respective trade receivable as a

    compensation, if the clients fail to pay their obligations (see also note 31).

    3.12.8 Foreign currency risk

    The Company enters into international transactions related mainly to the purchases of raw materials,

    sales of finished goods and loans (see note 2.3). Metal hedge operations are completed at cross

    currency rates to eliminate the currency risk between the selling price currency and purchase currency

    of metals for each order. Therefore, metal hedge operations cover both risk associated with changes in

    market prices of the metals on the London Metal Exchange and foreign currency risk (see also notes

    24 and 31).

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 51

    3 Significant accounting policies (continued)

    3.12 Financial instruments (continued)

    3.12.9 Liquidity risk

    The liquidity risk arises from the time difference in the contracted maturities of the monetary

    liabilities and the possibility that the liabilities are not settled on maturity. The Company manages this

    risk by using appropriate methods of planning, including providing overdrafts, daily liquidity reports,

    short-term and mid-term cash flows forecasts (see also note 31).

    3.13 Accruals

    Accruals are recognized when the Company has a present obligation as a result of a past event, and it

    is probable that the Company will be required to settle that obligation. Accruals are measured at the

    management’s best estimate of the expenditure required to settle the obligation at the end of the

    reporting period, and are discounted to present value where the effect is material.

    3.14 Government grants

    Government grants, (financing, government grants), are assistance by the government, government

    agencies and similar bodies in the form of transfers of resources to the Company in return for future

    compliance with certain conditions relating to the operating activities of the Company. Government

    grants may be (i) related to assets and (ii) related to income.

    Government grants are recognized when there is reasonable assurance that: (i) the Company will

    comply with the conditions attaching to them; and (ii) the grants will be received.

    The government grants received by the Company are related to assets and the main condition is to

    purchase, produce or acquire in other manner property, plant and equipment. They are presented in

    the statement of financial position as deferred income, that are recognized as income on a systematic

    and rational basis over the useful life of the acquired assets.

    3.15 Critical accounting judgements and key sources of estimation uncertainty

    The application of IFRS requires management to apply certain accounting assumptions and

    accounting estimates in the preparation of the financial statements, which affect the reported assets,

    liabilities and disclosures of contingent assets and liabilities as at the end of the reporting period and

    the amounts of revenue and expenses reported during the period. All of them are based on the best

    estimate of management as of the date of the preparation of the financial statements. The actual

    results may differ from those presented in these financial statements.

    The key assumptions concerning the future and other key sources of estimation uncertainty at the end

    of the reporting period, that have a significant risk of causing a material adjustment to the carrying

    amounts of assets and liabilities within the next financial year, are: the useful lives and fair value of

    property, plant and equipment (note 3.7), impairment of assets (note 3.10), fair value of investment

    property (note 3.9), fair value of derivatives (note 3.12) and the retirement benefits obligation

    (note 3.5).

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 52

    4 Revenue

    Revenue can be analyzed by markets as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Export 272,091 257,047

    Domestic 21,444 22,624

    Total revenue 293,535 279,671

    Revenue can be analyzed by products as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Foils 115,746 119,896

    Extrusion, pipes and other 99,271 81,583

    Strip and sheets 78,518 78,192

    Total revenue by products 293,535 279,671

    5 Cost of sales

    Cost of sales consists of the following:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Materials, fuels and electricity 243,724 235,041

    Personnel costs 13,825 11,903

    Depreciation 11,170 9,111

    Other 307 236

    Total cost of sales 269,026 256,291

    Cost of sales can be analyzed by products as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Foils 97,965 99,862

    Extrusion, pipes and other 93,045 78,389

    Strip and sheets 78,016 78,040

    Total cost by products 269,026 256,291

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 53

    6 Other income

    Other income consists of the following:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Sales of materials 6,630 6,027

    Insurances indemnities 294 197

    Sales of services 248 301

    Payables written-off 55 15

    Income from rents 48 56

    Income from government grants (note 27) 47 -

    Other 257 267

    Total other income 7,579 6,863

    7 Administrative expenses

    Administrative expenses consist of the following:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Personnel expenses 5,149 5,141

    Depreciation and amortization 738 696

    Insurance expenses 519 610

    Repairs and maintenance 508 356

    Security 429 408

    Transportation and business travel 421 414

    Taxes 299 297

    Donations 289 258

    Ecology 213 378

    Materials 155 142

    Communication expenses 124 121

    Receivables written-off 150 34

    Consulting services 112 106

    Fines and tax audits expenses 104 8

    Rents 77 101

    Other 377 353

    Total administrative expenses 9,664 9,423

    Expenses on audit of the financial statements of the Company, presented as part of the administrative

    expenses for 2014 and 2013 amount to BGN 36 thousand and BGN 39 thousand, respectively.

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 54

    8 Distribution expenses

    Distribution expenses are, as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Transportation 8,546 7,642

    Sales commissions 1,357 720

    Personnel expenses 735 736

    Insurances 353 442

    Impairment of trade receivables and claims paid 216 795

    Advertisement expenses 178 67

    Materials 74 62

    Depreciation and amortization 12 11

    Other 121 111

    Total distribution expenses 11,592 10,586

    9 Other expenses

    Other expenses are, as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Cost of materials and services sold 4,198 4,430

    Loss on sales of property, plant and equipment 6 -

    Total other expenses 4,204 4,430

    10 Operating expenses by nature

    The expenses classified by function can be further analyzed by nature, as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Materials 242,239 239,073

    Personnel costs 19,220 17,993

    Depreciation 11,819 9,981

    Hired services 13,255 11,843

    Other expenses 2,106 2,518

    Changes in inventories of finished goods and work in progress 1,986 (4,183)

    Capitalized expenses (343) (925)

    Total 290,282 276,300

    Сost of sales 269,026 256,291

    Administrative expenses 9,664 9,423

    Distribution expenses 11,592 10,586

    Total 290,282 276,300

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 55

    11 Exchange rate gain/(loss), net

    Exchange rate gain/(loss) net comprises of the following:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Exchange rate gain 564 156

    Exchange rate loss (494) (338)

    Total exchange rate gain/(loss), net 70 (182)

    12 Interest expenses, net

    Interest expenses, net include the following:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Interest expenses on loans, gross (3,882) (3,915)

    Less capitalized interest (note 16) 100 1,075

    Interest expense on loans (3,782) (2,840)

    Interest income 158 150

    Financial costs on retirement benefits obligation (42) (51)

    Total interest expenses, net (3,666) (2,741)

    13 Other financial expenses, net

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Bank charges (421) (420)

    Gain/(loss) from derivative financial instruments 74 (22)

    Gain arising from transactions with securities - 53

    Total other financial expenses, net (347) (389)

    Gains arising from transactions with securities are due to repayments of principal and interest related

    to the ZUNK loan (see also note 26).

  • АLCOMET AD

    NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

    for the year ended December 31, 2014 All amounts in thousand of BGN, unless otherwise stated

    This document is a translation of the original in Bulgarian, in case of divergence the Bulgarian original is prevailing 56

    14 Income taxes

    The deferred tax assets and liabilities accrued, are as follows:

    December 31,

    2014

    December 31,

    2013

    Deferred tax assets:

    Expenses regarding employee benefits 152 185

    Receivables written-off 30 71

    Accrued and unpaid remunerations 19 47

    Derivative financial instruments - 116

    Total deferred tax assets 201 419

    Deferred tax liabilities:

    Derivative financial instruments 83 -

    Investment property 248 248

    Property, plant and equipment 3,788 4,307

    Total deferred tax liabilities 4,119 4,555

    Total deferred tax liabilities, net 3,918 4,136

    A reconciliation of the effective tax rate is provided in the table below:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Profit before taxation 2,685 2,492

    Statutory tax rate 10% 10%

    Income tax (269) (249) Tax effect of permanent differences (9) (5)

    Recorded tax expense (278) (254)

    Effective tax rate 10.35% 10.19%

    Income tax expense is as follows:

    Year ended

    December 31,

    2014

    Year ended

    December 31,

    2013

    Current tax expense on taxable profit (690) (805)

    Deferred tax income relating to the origination and reversal of

    temporary differences during the current period 412 551

    Income tax expense (278) (254)

    The deferred tax for 2014 and 2013, charged directly to equity is at the amount of BGN 194 thousand

    decrease and BGN 139 thousand increase, r


Recommended